Colgate Palmolive (CL) Invested Capital (2009 - 2026)

Colgate Palmolive has reported Invested Capital for 18 years, with the latest figure at $8.4 billion in Q2 2026.

• On a quarterly basis, Invested Capital fell 14.14% year-over-year to $8.4 billion in Q2 2026; TTM through Jun 2026 was $8.4 billion, a 14.14% decrease from a year earlier, with the FY2025 full-year figure at $8.4 billion, down 8.74% from the prior year.
• Invested Capital was $8.4 billion for Q2 2026 at Colgate Palmolive, roughly flat from $8.5 billion in the prior quarter.
• The five-year high for Invested Capital was $9.8 billion in Q2 2025, with the low at $8.3 billion in Q1 2022.
• Average Invested Capital over 5 years is $9.1 billion, with a median of $9.2 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Invested Capital rose 16.5% in 2022, then dropped 14.14% in 2026.
• Over 5 years, Invested Capital stood at $9.6 billion in 2022, then retreated by 0.48% to $9.5 billion in 2023, then dropped by 3.92% to $9.2 billion in 2024, then decreased by 8.74% to $8.4 billion in 2025, then grew by 0.84% to $8.4 billion in 2026.
• The last three Invested Capital figures came in at $8.4 billion (Q2 2026), $8.5 billion (Q1 2026), and $8.4 billion (Q4 2025), per Business Quant data.